Evaluation of Compliance to Clinical, Paraclinical and Therapeutic Follow-Up in Patients with Chronic Hepatitis B Virus at the Yalgado Ouedraogo University Hospital in Ouagadougou

Aims: To evaluate the clinical, paraclinical and therapeutic compliance of patients with chronic hepatitis B virus at the Department of Hepato-Gastroenterology in Yalgado Ouedraogo University Hospital. Patients and Methods: This is a prospective, descriptive and analytical cross-sectional study conducted over a period of 3 months on patients who were chronic carriers of the hepatitis B virus and who had given their consent. Compliance was assessed using the GIRERD adherence assessment test and the visual analogue scale (VAS). Results: A total of 104 patients were included, 61 of whom were men (58.6%). The mean age was 40.2 years with a standard deviation of 12.6 years. Sixty-three patients (60.6%) were treated with tenofovir. Three-quarters of the patients were compliant with their six-monthly clinical follow-up and 25% had adequate paraclinical follow-up. Tenofovir supply disruption was the cause of treatment discontinuation in 30.4% of cases. Factors associated with compliance were female sex, monthly income and age. Factors associated with regularity of the follow-up were distance, higher level of education and being a shopkeeper. Conclusions: Our study showed good compliance to clinical follow-up but an inadequate adherence to paraclinical follow-up. A good understanding of the determinants of compliance is needed to incorporate them into clinical practice to ensure optimal patient care.